Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

BUY
$0.94 - $1.43 $33,804 - $51,425
35,962 Added 174.4%
56,583 $69,000
Q4 2021

Feb 08, 2022

BUY
$1.07 - $2.01 $21,395 - $40,191
19,996 Added 3199.36%
20,621 $26,000
Q3 2021

Nov 15, 2021

BUY
$1.96 - $4.72 $1,225 - $2,950
625 New
625 $1,000

About Acasti Pharma Inc.


  • Ticker ACST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,610,100
  • Market Cap $145M
  • Description
  • Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
More about ACST
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.